NR1H4 and cancer: Furthermore, butyrate influences the immunological response of the liver against cancer proliferation; the inhibition of FXR, by reversion of conjugated BAs via butyrate, controls the accumulation of hepatic natural killer T (NKT) cells and favours an NKT-related antitumor effect [133].